| 中国学者近期发表的论文 |
|---|
| 1. | A new rat model of bone cancer pain produced by rat breast cancer cells implantation of the shaft of femur at the third trochanter level.
Author: Gui Q, Xu C, Zhuang L, Xia S, Chen Y, Peng P, Yu S.
Journal: Cancer Biol Ther. 2013 Feb;14(2):193-9. doi: 10.4161/cbt.23291. Epub 2012 Dec 19. | | 2. | IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.
Author: Wang M, Wang L, Ren T, Xu L, Wen Z.
Journal: Cancer Biol Ther. 2013 Feb;14(2):155-63. doi: 10.4161/cbt.22955. Epub 2012 Nov 28. | | 3. | Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.
Author: Zhang Y, Yang JM.
Journal: Cancer Biol Ther. 2013 Feb;14(2):81-9. doi: 10.4161/cbt.22958. Epub 2012 Nov 28. | | 4. | Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells.
Author: Ou Y, Ma L, Ma L, Huang Z, Zhou W, Zhao C, Zhang B, Song Y, Yu C, Zhan Q.
Journal: Cancer Biol Ther. 2013 Jan;14(1):45-55. doi: 10.4161/cbt.22627. Epub 2012 Oct 31. | | 5. | Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.
Author: Wang DM, Liu L, Fan L, Zou ZJ, Zhang LN, Yang S, Li JY, Xu W.
Journal: Cancer Biol Ther. 2012 Dec 1;13(14):1522-8. doi: 10.4161/cbt.22252. Epub 2012 Oct 10. | | 6. | Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression.
Author: Luo CQ, Yeung SC, Liu ZG, Meng J, Zhong FT, Cheng C.
Journal: Cancer Biol Ther. 2012 Dec 1;13(14):1384-9. doi: 10.4161/cbt.22253. Epub 2012 Sep 17. | | 7. | Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.
Author: Feng JM, Miao ZH, Jiang Y, Chen Y, Li JX, Tong LJ, Zhang J, Huang YR, Ding J.
Journal: Cancer Biol Ther. 2012 Dec 1;13(14):1396-406. doi: 10.4161/cbt.22000. Epub 2012 Sep 6. | | 8. | Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice.
Author: Cheng M, Liu Z, Wan T, He B, Zha B, Han J, Chen H, Yang F, Li Q, Wang W, Xu H, Ye T.
Journal: Cancer Biol Ther. 2012 Dec 1;13(14):1407-16. doi: 10.4161/cbt.22001. Epub 2012 Sep 6. | | 9. | A pilot study of paclitaxel combined with gemcitabine followed by interleukin-2 and granulocyte macrophage colony-stimulating factor for patients with metastatic melanoma.
Author: Peng RQ, Ding Y, Zhang X, Liao Y, Zheng LM, Zhang XS.
Journal: Cancer Biol Ther. 2012 Dec 1;13(14):1443-8. doi: 10.4161/cbt.22005. Epub 2012 Sep 6. | | 10. | The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma.
Author: Zhang B, Shan H, Li D, Li ZR, Zhu KS, Jiang ZB.
Journal: Cancer Biol Ther. 2012 Oct;13(12):1175-84. doi: 10.4161/cbt.21347. Epub 2012 Aug 24. |
|
